证券代码：002105 证券简称：信隆健康 深圳信隆健康产业发展股份有限公司 投资者关系活动记录表 编号：2021-008 | --- | --- | --- | --- | |-----------------------------|-----------------------------------------|--------------|---------------------------------------------------------------------------------------------------------------------| | | | | | | | ■ 特定对象调研 | □ 分析师会议 | | | | □ 媒体采访 | □ 业绩说明会 | | | 投资者关系活动 类别 | □ 新闻发布会 | □ 路演活动 | | | | □ 现场参观 | | | | | □ 其它 | | （请文字说明其它活动内容） | | 参与单位名称及 人员姓名 | 国富基金管理有限公司 | | 孙萌 | | 时间 2021 | 年 09 月 09 日， | | 19:20-- ...

证券代码：002105 证券简称：信隆健康 深圳信隆健康产业发展股份有限公司 投资者关系活动记录表 编号：2021-010 | --- | --- | --- | --- | |-----------------------|-----------------------------|----------------------------------------------------------|-------| | | | | | | | ■ 特定对象调研 | □ 分析师会议 | | | 投资者关系活动 | □ 媒体采访 | □ 业绩说明会 | | | 类别 | □ 新闻发布会 | □ 路演活动 | | | | □ 现场参观 | | | | | ■ 其它 （电话会议） | | | | | | | | | | 中泰证券研究所 | 张帆 华泰证券资管 逯海燕 | | | | 顶天投资 | 张超 农银汇理 周宁 | | | | 华宝基金 吴心怡 | 长城自营 赵浩然 | | | | 天弘基金 李文静 | 红土创新 廖星昊 | | | 参与单位名称及 | | | | | | 中意资产 | 臧怡 浦银安盛 姚卫巍 ...

证券代码：002105 证券简称：信隆健康 深圳信隆健康产业发展股份有限公司 投资者关系活动记录表 编号：2021-011 | --- | --- | --- | --- | --- | |-------------------------|---------------------------------------------|--------------|----------------------------------------------------------|-----------| | | | | | | | | ■ 特定对象调研 | □ 分析师会议 | | | | 投资者关系活动 | □ 媒体采访 | □ 业绩说明会 | | | | 类别 | □ 新闻发布会 | □ 路演活动 | | | | | □ 现场参观 | | | | | | ■ 其它 （ 电话会议 ） | | | | | 参与单位名称及 人员姓名 | 中泰证券研究所 张帆 南方基金 张磊、梁嘉烁 | | | | | 时间 2021 | 年 10 月 25 日， | 15:30--16:30 | | | | | 地点 公司会议室 ...

证券代码：002105 证券简称：信隆健康 深圳信隆健康产业发展股份有限公司 投资者关系活动记录表 编号：2022-001 | --- | --- | --- | --- | --- | --- | --- | |---------------------|---------------------------------------------|----------------------------|---------------------------------------------------------|-------|-------|-------| | | | | | | | | | | ■ 特定对象调研 □ 媒体采访 | □ 分析师会议 □ 业绩说明会 | | | | | | 投资者关系活动 类别 | □ 新闻发布会 | □ 路演活动 | | | | | | | □ 现场参观 | | | | | | | | □ 其它 | （请文字说明其它活动内容） | | | | | | 参与单位名称及 | 浙商证券 杜山、文煊 建信保险资管 吴志豪 | | | | | | | 人员姓名 | 兆天投资 李 ...

证券代码：002105 证券简称：信隆健康 深圳信隆健康产业发展股份有限公司 投资者关系活动记录表 编号：2022-004 | --- | --- | --- | |-------------------------|-----------------------------------------------------------|-----------------------------------------------------------------------------------------------------------| | | ■ 特定对象调研 | □ 分析师会议 | | | □ 媒体采访 | □ 业绩说明会 | | 投资者关系活动 类别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | ■ 其它 （ 线上会议 ） | | | 参与单位名称及 人员姓名 | 国金证券 张杨恒、张敏敏、李喆莹 汇添富基金 蔡志文、费海墅 | | | 时间 | 2022 年 02 月 17 日， | 21:00--22:00 | | | 地点 公司会议室 | | | 上市 ...

证券代码：002105 证券简称：信隆健康 深圳信隆健康产业发展股份有限公司 投资者关系活动记录表 编号：2022-002 | --- | --- | --- | --- | --- | --- | --- | |-------------------------|----------------------------|----------------------------------------------------------|----------------------|-------|-------|-------| | | | | | | | | | | ■ 特定对象调研 □ 媒体采访 | □ 分析师会议 □ 业绩说明会 | | | | | | 投资者关系活动 类别 | □ 新闻发布会 | □ 路演活动 | | | | | | | □ 现场参观 | | | | | | | | □ 其它 | （请文字说明其它活动内容） | | | | | | 参与单位名称及 人员姓名 | 万家基金 王晨曦 国元证券 | 徐偲、许元琨、刘雨航、马灵均 | | | | | | 时间 2022 | 年 01 月 11 ...

证券代码：002105 证券简称：信隆健康 深圳信隆健康产业发展股份有限公司 投资者关系活动记录表 编号：2022-010 | --- | --- | --- | --- | |-------------------------|-------------------|----------------------------|------------------------------------------------------------| | | | | | | | | | | | | ■ 特定对象调研 | □ 分析师会议 | | | | □ 媒体采访 | □ 业绩说明会 | | | 投资者关系活动 类别 | □ 新闻发布会 | □ 路演活动 | | | | □ 现场参观 | | | | | □ 其它 | （请文字说明其它活动内容） | | | 参与单位名称及 人员姓名 | 招商证券 赵中平 | | | | 时间 2022 | 年 09 月 28 | 14:30--14:30 | | | | 地点 公司会议室 | | | | 上市公司接待人 员姓名 | 陈丽秋 | | | | | 1. 何？ | | ...

Financial Performance - The company's revenue for Q3 2022 was ¥415,025,715.79, a decrease of 35.37% compared to the same period last year[4] - Net profit attributable to shareholders was ¥62,870,572.40, down 18.99% year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥54,832,112.51, a decline of 26.43% compared to the previous year[4] - The company experienced a 23.13% decline in total revenue for the first nine months of 2022, totaling ¥1,470,016,977.28[9] - Total operating revenue for the current period is ¥1,470,016,977.28, a decrease of 23.1% compared to ¥1,912,457,854.82 in the previous period[17] - Net profit for the current period is ¥205,890,796.80, a decline of 8.7% from ¥225,561,947.18 in the previous period[18] - Basic earnings per share for the current period is 0.516, compared to 0.556 in the previous period, reflecting a decrease of 7.2%[19] Assets and Liabilities - The total assets at the end of Q3 2022 were ¥1,970,861,326.33, a decrease of 13.65% from the end of the previous year[4] - The company’s total liabilities decreased by 13.65% compared to the end of the previous year[4] - Total current assets as of September 30, 2022, amount to ¥1,325,392,627.57, a decrease from ¥1,641,686,202.93 at the beginning of the year[15] - Total liabilities decreased to ¥907,363,060.64 from ¥1,338,888,575.65[16] - Long-term borrowings decreased to ¥58,438,531.82 from ¥88,998,534.44[16] Cash Flow - The cash flow from operating activities for the year-to-date was ¥206,448,259.93, an increase of 87.41% compared to the same period last year[4] - Cash flow from operating activities for the current period is ¥206,448,259.93, an increase of 87.0% from ¥110,158,422.51 in the previous period[20] - Cash flow from investing activities shows a net outflow of ¥40,723,436.96, improving from a net outflow of ¥87,598,323.25 in the previous period[21] - Cash flow from financing activities results in a net outflow of ¥200,604,289.29, compared to a smaller net outflow of ¥6,005,841.26 in the previous period[21] - The ending cash and cash equivalents balance is ¥431,808,546.64, down from ¥459,199,753.69 at the beginning of the period[21] Shareholder Information - Total number of common shareholders at the end of the reporting period is 20,865[11] - The largest shareholder, Litian Development Co., Ltd., holds 41.93% of shares, totaling 154,522,500 shares[11] - The company has no preferred shareholders among the top ten shareholders[12] Other Financial Metrics - Research and development expenses for the year-to-date were ¥43,969,187.88, a decrease of 21.67% compared to the previous year[9] - Cash and cash equivalents decreased to ¥431,808,546.64 from ¥459,199,753.69[14] - Accounts receivable decreased significantly to ¥456,237,670.13 from ¥636,496,632.73[14] - Inventory decreased to ¥320,770,164.60 from ¥435,013,849.64[15] - Total equity increased to ¥1,063,498,265.69 from ¥943,627,818.06[16] - Other comprehensive income after tax for the current period is ¥8,713,647.26, significantly higher than ¥1,227,921.29 in the previous period[18] - The company has not undergone an audit for the third quarter report[22]

Financial Performance - The company's operating revenue for the first half of 2022 was CNY 1,054,991,261.49, a decrease of 16.95% compared to CNY 1,270,263,768.02 in the same period last year[20]. - The net profit attributable to shareholders of the listed company was CNY 125,132,833.08, showing a slight increase of 0.02% from CNY 125,102,234.06 year-on-year[20]. - The net cash flow from operating activities significantly improved to CNY 79,198,248.76, an increase of 538.90% compared to CNY 12,396,038.70 in the previous year[20]. - Total assets at the end of the reporting period were CNY 2,140,167,781.61, down 6.24% from CNY 2,282,516,393.71 at the end of the previous year[20]. - The net assets attributable to shareholders increased by 4.21% to CNY 888,897,855.86 from CNY 852,946,415.37 at the end of the previous year[20]. - The basic and diluted earnings per share remained unchanged at CNY 0.343[20]. - The weighted average return on equity decreased to 13.67%, down 3.50% from 17.17% in the previous year[20]. - The company reported non-recurring gains and losses totaling CNY 10,529,587.79 for the period[24]. - The company's total revenue for the first half of 2022 was CNY 1,054.99 million, a decrease of 16.95% year-on-year, with foreign revenue increasing by 17.41% to CNY 710.14 million, while domestic revenue fell by 48.18% to CNY 344.85 million[59]. - The company's net profit attributable to shareholders was CNY 125.13 million, remaining stable with a slight increase of 0.02% compared to the previous year, primarily due to a significant increase in exchange gains from the depreciation of the RMB against the USD[59]. - The company's cash flow from operating activities showed a substantial increase of 538.90%, reaching CNY 79.20 million, attributed to improved sales collections[60]. Market Trends and Demand - The European market is projected to see electric bicycle demand exceed 5 million units in 2022, with a significant shift towards electric assist bicycles and cargo bicycles due to changing consumer preferences[38]. - The company anticipates that the demand for electric assist bicycles in the EU will continue to grow, with a forecast of over 6.5 million units sold by 2025[34]. - The domestic market is experiencing increased demand for shared bicycles and mid-to-high-end sports bicycles, driven by post-pandemic personal travel trends[40]. - By 2030, Europe is expected to sell 30 million bicycles annually, a 47% increase from 2019, with e-bike sales projected to grow from 3 million units in 2019 to 17 million units[41]. - The global bicycle market is forecasted to expand by 37.5% from 2019 to 2024, with revenues reaching $62 billion, and the e-bike market value expected to hit $24.4 billion by 2024[41]. - The global electric scooter market is projected to reach a production volume of 10.01 million units and a market value of $3.341 billion by 2027, with a compound annual growth rate of approximately 14.99% from 2021 to 2027[44]. - The global smart electric scooter market could reach $50 billion by 2025, with North America accounting for $15 billion and China for $8 billion[45]. - The electric wheelchair market in China is experiencing steady growth, driven by an increasing demand from the aging population, which includes 264 million individuals aged 60 and above, representing 18.7% of the total population[54]. Company Strategy and Operations - The company has established production bases in South China and North China, and has set up a facility in Vietnam to mitigate the impacts of the US-China trade war and stringent anti-dumping policies in Europe[28]. - The company is focusing on cross-industry collaborations and product development to adapt to the evolving market landscape and consumer preferences[40]. - The company has successfully developed a series of wheelchairs in collaboration with top global companies, enhancing its competitive edge in the rehabilitation equipment sector[31]. - The company’s automated welding technology in the sports equipment sector has achieved over 98% automation, allowing for large-scale order production[30]. - The company plans to expand its market presence through new product launches and strategic partnerships in the upcoming quarters[158]. - The company aims to enhance its market expansion strategies, particularly in the health industry, to drive future revenue growth[162]. - The company is actively investing in new product development and technological advancements to stay competitive in the market[162]. Financial Position and Investments - Cash and cash equivalents at the end of the reporting period were CNY 409,856,172.72, a decrease of 0.97% from CNY 459,199,753.69 at the end of the previous year[68]. - Short-term borrowings increased by 3.56% to CNY 512,336,390.73, compared to CNY 465,192,826.93 at the end of the previous year[68]. - The company reported an investment loss of CNY 2,353,981.12, primarily due to losses from its associate Tian Teng Power[66]. - Total investment during the reporting period was CNY 43,006,250.78, an increase of 8.53% compared to CNY 39,627,691.30 in the same period last year[72]. - The company recognized a performance compensation income of CNY 17,630,400.20 from its associate Tian Teng Power due to unmet performance commitments[70]. - The company's asset-liability ratio stood at 53.58% at the end of the reporting period, indicating potential financial risk[80]. - The main raw materials include steel pipes, aluminum pipes, and aluminum ingots, with cost control measures in place to mitigate price fluctuations[80]. Environmental and Social Responsibility - No significant environmental pollution issues were reported, and all pollution control facilities are operating normally[89]. - The company has established an emergency response plan for environmental incidents, which was approved in December 2018[91]. - The company is committed to fulfilling its social responsibilities and supporting public welfare initiatives in the future[96]. - The company has not engaged in any significant asset or equity sales during the reporting period[76][77]. - The company has not reported any changes in the scope of consolidation compared to the previous year, ensuring stability in its operations[171]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 20,773[127]. - The largest shareholder, LITIAN DEVELOPMENT CO., LTD., holds 41.93% of the shares, totaling 154,522,500 shares[127]. - FERNANDO CORPORATION is the second-largest shareholder with a 5.68% stake, amounting to 20,926,447 shares[127]. - The report indicates that there are no shareholders with pledged, marked, or frozen shares among the top 10 shareholders[127]. - The company has not conducted any repurchase transactions during the reporting period[128]. Compliance and Governance - The company has a well-structured governance framework, including a board of directors and various specialized committees[169]. - The company adheres to the accounting standards set by the Ministry of Finance, ensuring that financial statements accurately reflect its financial position, operating results, and cash flows[175]. - The company confirms that there are no significant doubts regarding its ability to continue as a going concern for the next 12 months[173]. - The financial report for the first half of 2022 was not audited[138].

Financial Performance - The company's revenue for Q1 2022 was ¥511,351,040.77, a decrease of 12.67% compared to ¥585,539,472.88 in the same period last year[3] - Net profit attributable to shareholders was ¥45,395,423.02, down 23.57% from ¥59,397,700.22 year-on-year[3] - Total operating revenue for Q1 2022 was RMB 511,351,040.77, a decrease of 12.6% compared to RMB 585,539,472.88 in the same period last year[15] - Operating profit for Q1 2022 was RMB 57,840,592.69, compared to RMB 70,429,974.32 in Q1 2021, reflecting a decline of 18.0%[16] - The total comprehensive income attributable to the parent company was CNY 45.47 million, compared to CNY 59.43 million in Q1 2021, reflecting a decrease of 23.5%[20] - The net profit for Q1 2022 was CNY 51.93 million, down 20.38% from CNY 65.25 million in Q1 2021[20] Cash Flow and Liquidity - The net cash flow from operating activities improved significantly to ¥15,248,893.03, compared to a negative cash flow of ¥15,971,124.05 in the previous year, marking a 195.48% increase[3] - The net cash flow from operating activities was CNY 15.25 million, a significant improvement from a net outflow of CNY 15.97 million in the same period last year[21] - Cash and cash equivalents at the end of Q1 2022 were RMB 458,910,565.65, slightly down from RMB 459,199,753.69 at the beginning of the year[12] - The cash and cash equivalents at the end of Q1 2022 were CNY 458.91 million, slightly down from CNY 459.20 million at the beginning of the quarter[21] - The cash outflow from investing activities was CNY 15.73 million, a decrease from CNY 17.64 million in Q1 2021[21] - The cash flow from financing activities showed a net inflow of CNY 35.19 thousand, compared to a net outflow of CNY 18.86 million in Q1 2021[21] Assets and Liabilities - Total assets decreased by 5.67% to ¥2,153,063,155.26 from ¥2,282,496,355.80 at the end of the previous year[3] - The company's total assets as of March 31, 2022, were RMB 2,153,063,155.26, down from RMB 2,282,496,355.80 at the beginning of the year, a decrease of 5.6%[15] - Total liabilities decreased to RMB 1,157,427,705.21 from RMB 1,338,849,640.65, representing a reduction of 13.5%[14] Shareholder Equity and Earnings - The company's equity attributable to shareholders increased by 5.33% to ¥898,415,685.89 from ¥852,965,312.46 at the end of the previous year[3] - The company's equity attributable to shareholders increased to RMB 898,415,685.89 from RMB 852,965,312.46, an increase of 5.3%[15] - The basic earnings per share decreased by 23.31% to ¥0.125 from ¥0.163 in the same period last year[3] - The company reported a basic and diluted earnings per share of CNY 0.125, compared to CNY 0.163 in Q1 2021[20] - The weighted average return on equity fell to 5.18%, down 3.51% from 8.69% in the previous year[3] Operating Costs and Subsidies - The company experienced a 13.66% reduction in operating costs, which amounted to ¥402,172,166.09 compared to ¥465,801,927.60 in the previous year[6] - Total operating costs for Q1 2022 were RMB 453,050,530.40, down 12.0% from RMB 514,947,064.30 year-on-year[15] - The company reported a significant increase in government subsidies, totaling ¥660,725.34, up 51.27% from ¥436,777.60[7] Investment Performance - The company’s investment income showed a substantial loss of ¥1,084,423.13, which is a 92.94% increase in losses compared to the previous year[7] - The company reported a net investment loss of RMB 1,084,423.13 in Q1 2022, compared to a loss of RMB 562,047.23 in the previous year[15] Other Information - The company did not report any new product launches or significant market expansion strategies during this quarter[22] - The company received tax refunds amounting to CNY 30.02 million, an increase from CNY 17.83 million in the previous year[20]